TACR1 and glioma: SP increased the expression and secretion of interleukin-8 (IL-8), a target gene controlled by NF-κB, and this effect is specific, since an NK-1R antagonist completely prevented NF-κB activation in response to SP, but not to IL-1β, in U-373 MG glioma cells [69].